Home/Filings/4/0001610618-21-000029
4//SEC Filing

Sandison Taylor 4

Accession 0001610618-21-000029

CIK 0001610618other

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 3:16 PM ET

Size

4.8 KB

Accession

0001610618-21-000029

Insider Transaction Report

Form 4
Period: 2021-03-31
Sandison Taylor
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2021-03-31+70082,031 total
Footnotes (1)
  • [F1]The reporting person was previously granted a performance restricted stock unit (PRSU) to vest upon the achievement of a certain milestone event that occurred on 3/31/21.

Issuer

Cidara Therapeutics, Inc.

CIK 0001610618

Entity typeother

Related Parties

1
  • filerCIK 0001702287

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 3:16 PM ET
Size
4.8 KB